Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Clinical trial NCT01405911 · COMPLETED

Trial details

NCT number: NCT01405911
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glucose Intolerance

Start date: 2011-08-16
Primary completion: 2012-04-09
Enrollment: 242

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.